Health ❯ Medical Research ❯ Clinical Trials

Drug Development

Monoclonal Antibodies FDA-Approved Treatments Neurosurgery Teclistamab Oncology PAR1 Targeting Parkinson's Disease Gene-Editing Treatments Innovative Treatments Alopecia Areata Immunology

Nektar’s Alopecia Drug Misses Phase 2b Goal as Company Cites Ineligible Patients, Plans Phase 3

Nektar points to eligibility violations inflating the placebo response as it charts a Phase 3 path.

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

PAR1 Receptor Drives Lung Lymphatic Remodeling to Accelerate Fluid Clearance